Correlation Between IShares MSCI and Tema Oncology
Can any of the company-specific risk be diversified away by investing in both IShares MSCI and Tema Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares MSCI and Tema Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares MSCI China and Tema Oncology ETF, you can compare the effects of market volatilities on IShares MSCI and Tema Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares MSCI with a short position of Tema Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares MSCI and Tema Oncology.
Diversification Opportunities for IShares MSCI and Tema Oncology
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between IShares and Tema is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding iShares MSCI China and Tema Oncology ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tema Oncology ETF and IShares MSCI is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares MSCI China are associated (or correlated) with Tema Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tema Oncology ETF has no effect on the direction of IShares MSCI i.e., IShares MSCI and Tema Oncology go up and down completely randomly.
Pair Corralation between IShares MSCI and Tema Oncology
Given the investment horizon of 90 days iShares MSCI China is expected to generate 1.07 times more return on investment than Tema Oncology. However, IShares MSCI is 1.07 times more volatile than Tema Oncology ETF. It trades about 0.3 of its potential returns per unit of risk. Tema Oncology ETF is currently generating about 0.09 per unit of risk. If you would invest 4,493 in iShares MSCI China on November 9, 2024 and sell it today you would earn a total of 419.00 from holding iShares MSCI China or generate 9.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
iShares MSCI China vs. Tema Oncology ETF
Performance |
| Timeline |
| iShares MSCI China |
| Tema Oncology ETF |
IShares MSCI and Tema Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with IShares MSCI and Tema Oncology
The main advantage of trading using opposite IShares MSCI and Tema Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares MSCI position performs unexpectedly, Tema Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tema Oncology will offset losses from the drop in Tema Oncology's long position.| IShares MSCI vs. KraneShares CSI China | IShares MSCI vs. Invesco China Technology | IShares MSCI vs. iShares MSCI India | IShares MSCI vs. Xtrackers Harvest CSI |
| Tema Oncology vs. Freedom Day Dividend | Tema Oncology vs. Franklin Templeton ETF | Tema Oncology vs. iShares MSCI China | Tema Oncology vs. Tidal Trust II |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |